Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Exploration of Targeted Anti-Tumor Therapy|September 25, 2023
Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancerAbhishek Mahajan, Gurukrishna B, Shweta Wadhwa, et al.
BMC Cancer|May 21, 2025
Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trialArchya Dasgupta, Shakthivel Mani, Abhishek Chatterjee, et al.
The British Journal of Radiology|August 18, 2025
First-in-India Experience with 90Y-BhabhaSphere: An Indigenous 90Y-TheraSphere Biosimilar for Transarterial radioembolization of Hepatic MalignanciesAshish Kumar Jha, Ameya Puranik, Kunal Bharat Gala, et al.
South Asian Journal of Cancer|December 22, 2025
High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival OutcomesNoorzia Syed, Anant Ramaswamy, Aditya Dhanawat, et al.
Radiation Oncology (London, England)|February 14, 2026
Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE)Archya Dasgupta, Suman Ghosh, Abhishek Chatterjee, et al.
Frontiers in Nuclear Medicine|October 2, 2024
The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosisArpita Sahu, Ronny Mathew, Renuka Ashtekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized StudyVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based ChemoradiationVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
Pageof 7